Unlock instant, AI-driven research and patent intelligence for your innovation.

Crystal forms of camostat mesylate and solvate thereof as well as preparation method and application of crystal forms of camostat mesylate and solvate thereof

A technology of ester mesylate and crystal form, which is applied in the preparation of organic compounds, sulfonate preparation, chemical instruments and methods, etc., and can solve problems such as unfavorable drug stability

Pending Publication Date: 2021-11-23
TIANJIN INSTITUTE OF PHARMA RESEARCH +1
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It can be seen that the camostat mesylate prepared according to the existing literature is a mixed crystal form, which is unfavorable for the stability of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal forms of camostat mesylate and solvate thereof as well as preparation method and application of crystal forms of camostat mesylate and solvate thereof
  • Crystal forms of camostat mesylate and solvate thereof as well as preparation method and application of crystal forms of camostat mesylate and solvate thereof
  • Crystal forms of camostat mesylate and solvate thereof as well as preparation method and application of crystal forms of camostat mesylate and solvate thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] The preparation of embodiment 1 hydrate crystal form C

[0084]Add 5g of the free base to 25ml of deionized water, cool down to 10-15°C, add dropwise a methanesulfonic acid solution prepared by 1.2g methanesulfonic acid and 1.5g water, and keep the temperature not exceeding 20°C during the dropping process. After dropping, the system was dissolved and cleared, cooled to 0-5°C and stirred for 2 hours, and a solid was precipitated. Filter, rinse the filter cake with cold water, and blow dry at 50°C for 6h to obtain 3.1g of the compound of formula (I) 4-(4-guanidinobenzoyloxy)phenylacetic acid [2-(dimethylamino)-2 Hydrate form C of -oxoethyl] ester methanesulfonate.

Embodiment 2

[0085] The preparation of embodiment 2 acetone solvate crystal form E

[0086] 5 g of the free base was added to a mixture of 45 ml of acetone and 5 ml of deionized water, and a suspension was obtained under stirring. At 15-25°C, add dropwise a methanesulfonic acid solution prepared by 1.2g methanesulfonic acid and 2.4g water, and keep the temperature not exceeding 25°C during the dropping process. After dropping, the system dissolves and clears. The temperature was lowered to -10~0°C, and a solid was precipitated. Insulated and stirred for 2h, filtered, the filter cake was rinsed with acetone, and dried at 50°C for 4h to obtain 3.8g of formula (I) compound 4-(4-guanidinobenzoyloxy)phenylacetic acid [2-(dimethyl Acetonide form E of amino)-2-oxoethyl] ester mesylate.

Embodiment 3

[0087] Example 3 Preparation of N,N-dimethylformamide solvate crystal form F

[0088] 5 g of the free base was added to 15 ml of N,N-dimethylformamide, and a suspension was obtained under stirring. At 15-25°C, add 1.2g of methanesulfonic acid dropwise, and keep the temperature not exceeding 25°C during the dropwise addition. After dropping, the system dissolves and clears. The temperature was lowered to 0-5°C, and a solid was precipitated. Keep stirring for 2 hours, filter, rinse the filter cake with frozen N,N-dimethylformamide, and air-dry at 90°C for 5 hours to obtain 3.3g of compound 4-(4-guanidinobenzoyloxy) of formula (I) ) N,N-dimethylformamide solvate crystal form F of [2-(dimethylamino)-2-oxoethyl] phenylacetate methanesulfonate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a crystal form of camostat mesylate, a hydrate crystal form of the camostat mesylate, an acetone solvate crystal form of the camostat mesylate and an N, N-dimethylformamide solvate crystal form of the camostat mesylate as well as a preparation method and application of the crystal forms. The crystal form of the camostat mesylate and the hydrate crystal form of the camostat mesylate have good medicinal value. Therefore, the invention also provides application of the crystal form or the hydrate crystal form in preparation of medicines for treating pancreatitis, reflux esophagitis and diseases caused by coronavirus infection.

Description

technical field [0001] The present invention relates to the crystal forms of camostat mesylate and its solvate, their preparation method, their pharmaceutical preparation and their use in the treatment of acute pancreatitis. Background technique [0002] Camostat Mesilate (Camostat Mesilate) chemical name: 4-(4-guanidinobenzoyloxy) phenylacetic acid [2-(dimethylamino)-2-oxoethyl] ester methanesulfonic acid Salt, the structural formula is as follows: [0003] [0004] Molecular formula: C 20 h 22 N 4 o 5 ·CH 4 o 3 S, molecular weight: 494.52, CAS accession number: 57921-29-8. [0005] Camostat mesylate is an orally administered non-peptide proteolytic enzyme inhibitor, which can effectively inhibit the activities of trypsin, plasma kallikrein, plasmin, thrombin, C1r and C1 esterase, etc., and the The compound has no significant inhibitory effect on α-chymotrypsin, pepsin and pancreatic enzymes, so it can be used clinically to relieve acute symptoms of chronic pancr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C309/04C07C303/32C07C279/18C07C277/08A61K31/245A61P1/18A61P1/04A61P31/14
CPCC07C277/08C07C303/32A61K31/245A61P1/18A61P1/04A61P31/14C07B2200/13C07C279/18C07C309/04
Inventor 穆帅李树军雷永胜陈蔚闫少杰王浩张慕军周学福潘毅陈华刘福景孙靖汤立达
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH